Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 9 Squamous Cell Carcinoma of Head and Neck 4 Nasopharyngeal Carcinoma 4 Esophageal Squamous Cell Carcinoma 4 Carcinoma, Non-Small-Cell Lung 4 Uterine Cervical Neoplasms 3 Triple Negative Breast Neoplasms 3 Stomach Neoplasms 3 Esophageal Neoplasms 3 Pancreatic Neoplasms 2 Locally Advanced Rectal Cancer 2 Colonic Neoplasms 2 Cervical Cancer Metastatic 2 Breast Neoplasms 2 Adenocarcinoma 2 Turcot syndrome 1 Salivary Gland Neoplasms 1 Recurrence 1 Rectal Cancer Patients 1 Non-squamous Non-small-cell Lung Cancer 1 Mouth Neoplasms 1 Liver Neoplasms 1 Leukemia, Myeloid, Acute 1 Laryngeal Neoplasms 1 Gestational Trophoblastic Disease 1 Esophageal Squamour Cell Cancer 1 Endometrioid Endometrial Cancer 1 Colorectal Neoplasms 1 Biliary Tract Neoplasms 1 Advanced Primary Liver Cancer 1

Interventions

durvalumab 13 Bevacizumab 11 Nivolumab 10 tremelimumab 7 pembrolizumab 6 lenvatinib 6 fludarabine 6 Cyclophosphamide 6 atezolizumab 4 Radiosurgery 4 Cisplatin 4 toripalimab 3 relatlimab 3 Magnetic Resonance Imaging 3 Ipilimumab 3 Gemcitabine 3 X-Rays 2 Standard of Care 2 Sorafenib 2 Riluzole 2 Radiotherapy 2 Photons 2 Patient Navigation 2 Lidocaine 2 Hepatectomy 2 Dexamethasone 2 Biopsy 2 trastuzumab deruxtecan 1 tocilizumab 1 tislelizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Liver Neoplasms × camrelizumab × 1 year × Clear all

NCT07105748 2025-08-17

TASK-05

Fudan University

Phase 2 Recruiting

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡